Nancy Sajjadi will speak about the analytical challenges for adenovirus on Day 1 of the NIST-FDA Workshops on Measurements and Standards for Advanced Therapy and will attend Days 2 and 3 in person.

Day 1 will focus on identifying measurement needs, gaps and solutions for different gene delivery systems. In addition to adenovirus, other vector platforms covered will include:

• Lentiviral vectors (LVV)
• Adeno-associated virus (AAV)
• Lipid nanoparticles (LNP)
• Extracellular vesicles (EV)